Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 8 of 8 entries
Sorted by: Best Match Show Resources per page
A Safe and Easy Introduction of Darbepoetin-Alpha in Patients Receiving Maintenance Hemodialysis and Epoetin Monotherapy: A "Half-and-Half" Combination Therapy.

Current therapeutic research, clinical and experimental

Shimamatsu K, Inamasu H.
PMID: 24384988
Curr Ther Res Clin Exp. 2013 Jun;74:5-8. doi: 10.1016/j.curtheres.2012.12.001.

BACKGROUND: In hemodialysis (HD) patients requiring anemia management, the 3-fold longer terminal half-life (25.3 hours) of darbepoetin-alpha (DA) results in reduced dose frequency when compared with recombinant human erythropoietin (EPO) -alpha or -beta by intravenous administration (8.5 hours). However,...

Effect of occasional epoetin use in combination with a stable darbepoetin dosage on anemia management in hemodialysis patients.

ClinicoEconomics and outcomes research : CEOR

Shimamatsu K.
PMID: 25525375
Clinicoecon Outcomes Res. 2014 Dec 09;6:531-5. doi: 10.2147/CEOR.S73473. eCollection 2014.

AIM: Taking advantage of the characteristics of both darbepoetin (DA) and epoetin (EPO) might be a reasonable option for stabilizing hemoglobin (Hb) control in hemodialysis (HD) patients. The effect of DA assisted by EPO (DA/EPO) on Hb control was...

Regulation of platelet count by erythropoiesis-stimulating agents - iron axis in hemodialysis patients.

International journal of nephrology and renovascular disease

Koike K, Fukami K, Kawaguchi A, Shimamatsu K, Yamagishi S, Okuda S.
PMID: 27099526
Int J Nephrol Renovasc Dis. 2016 Mar 31;9:73-80. doi: 10.2147/IJNRD.S98196. eCollection 2016.

Higher doses of erythropoiesis-stimulating agents (ESAs) contribute to atherothrombotic cardiovascular disease in hemodialysis (HD) patients. Thrombocytosis is associated with increased mortality in ESA-treated HD patients. We investigated variables affecting platelet count and its variability (platelet count increment [Δplatelet count])...

Granulocyte-colony stimulating factor producing mucinous cystic neoplasm with an associated invasive carcinoma of the pancreas.

Oncology letters

Shimamatsu K, Naito Y, Mihara Y, Nakayama M, Tanigawa M, Abe Y, Nakamura K, Araki T, Sakata K, Noguchi K, Akiba J, Yano H, Nakashima O.
PMID: 29434948
Oncol Lett. 2018 Feb;15(2):2387-2392. doi: 10.3892/ol.2017.7572. Epub 2017 Dec 08.

The present case study documents an autopsy case of granulocyte-colony stimulating factor (G-CSF)-producing mucinous cystic neoplasm (MCN), with an associated invasive carcinoma of the pancreas. A 65-year-old woman presented to Omuta City Hospital (Omuta Japan) with a primary complaint...

Testicular sarcoidosis with bilateral scrotal swelling.

IJU case reports

Kimura S, Momozono K, Shimamatsu K, Noguchi M.
PMID: 32743456
IJU Case Rep. 2019 Oct 19;3(1):12-14. doi: 10.1002/iju5.12124. eCollection 2020 Jan.

INTRODUCTION: Sarcoidosis is a disease in which noncaseating granulomas form in several organs, particularly in the lungs and skin. Male genitourinary involvement in sarcoidosis is uncommon.CASE PRESENTATION: A 32-year-old male with painless bilateral scrotal swelling who was diagnosed with...

Significance of neoadjuvant chemoradiotherapy for borderline resectable pancreatic head cancer: Pathological local invasion and microvessel invasion analysis.

Molecular and clinical oncology

Naito Y, Ishikawa H, Sadashima E, Okabe Y, Takahashi K, Kawahara R, Hisaka T, Fukahori M, Ushijima T, Ishida Y, Tanigawa M, Mihara Y, Nakayama M, Kondo R, Kusano H, Takase Y, Abe H, Ogo E, Okuda K, Shimamatsu K, Yano H, Akiba J.
PMID: 31423309
Mol Clin Oncol. 2019 Sep;11(3):225-233. doi: 10.3892/mco.2019.1885. Epub 2019 Jun 20.

Borderline resectable pancreatic head cancer (BR-PHC) has low resectability due to vascular invasion. Although the clinical effects of neoadjuvant chemoradiotherapy (NAC-RT) for BR-PHC have been examined, few studies have reported its pathological aspects. The present study retrospectively investigated the...

Benign multicystic peritoneal mesothelioma mimicking recurrence of an ovarian borderline tumor: a case report.

Journal of medical case reports

Takemoto S, Kawano R, Honda K, Nakazono A, Shimamatsu K.
PMID: 22583977
J Med Case Rep. 2012 May 14;6:126. doi: 10.1186/1752-1947-6-126.

INTRODUCTION: Benign multicystic peritoneal mesothelioma is an extremely rare tumor that occurs mainly in women in their reproductive age. Its preoperative diagnosis and adequate treatment are quite difficult to attain.CASE PRESENTATION: Our patient was a 23-year-old Japanese woman who...

Hemodilution Impacts Assessment of Thyroid Status before and after Hemodialysis in Patients with End-Stage Renal Disease.

American journal of nephrology

Sanai T, Okamura K, Onoue T, Ono T, Motomura K, Miyazono M, Shimamatsu K.
PMID: 33524972
Am J Nephrol. 2021 Feb 01;51(12):988-994. doi: 10.1159/000512968. Epub 2021 Feb 01.

BACKGROUND: To elucidate the role of hemodilution in the alteration of thyroid hormone levels in end-stage renal disease (ESRD), we compared thyroid function before and after hemodialysis (HD).METHODS: Twenty-three male ESRD patients (age

Showing 1 to 8 of 8 entries